NCT07072650View on ClinicalTrials.gov

Impact of Adding Dexmedetomidine as an Adjuvant to The Local Anesthetic in Quadratus Lumborum Block in Patient Undergoing Caesarean Section

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 25, 2025

Primary Completion Date

May 10, 2025

Study Completion Date

June 25, 2025

Conditions

DexmedetomidineQuadratus Lumborum BlockPostoperative AnalgesiaCaesarean Section

Interventions

DRUG

Dexmedetomidine

Studying combining a local anesthetic with dexmedetomidine (DEX) in a quadratus lumborum block (QLB) following a cesarean section (CS) in elective surgery in Bint Al-Huda Hospital.

Trial Locations (1)

64001

Bint Al-Huda Hospital/ thi qar office directorate, Nasiriyah

All Listed Sponsors

lead

Majid Fakhir Mutar Alhamaaidah

OTHER

NCT07072650 - Impact of Adding Dexmedetomidine as an Adjuvant to The Local Anesthetic in Quadratus Lumborum Block in Patient Undergoing Caesarean Section | Biotech Hunter | Biotech Hunter